SPY441.40-4.34 -0.97%
DIA345.64-1.80 -0.52%
IXIC15,043.97-137.96 -0.91%

BRIEF-U.S. FDA Grants BRUKINSA (Zanubrutinib) Approval In Waldenström’S Macroglobulinemia

reuters.com · 09/01/2021 17:34
BRIEF-U.S. FDA Grants BRUKINSA (Zanubrutinib) Approval In Waldenström’S Macroglobulinemia

- Beigene Ltd BGNE:

  • U.S. FDA GRANTS BRUKINSA® (ZANUBRUTINIB) APPROVAL IN WALDENSTRÖM’S MACROGLOBULINEMIA

Source text for Eikon: ID:nBw6JG43ka

Further company coverage: BGNE


((Reuters.Briefs@thomsonreuters.com;))